Thank you, Madam Chair.
Thank you, witnesses, for being here.
As we hear about all the processes that are going on and the framework you're putting together, it would seem that most of the remedial action is at the back end of the process. A disease has to be discovered, and then you react to that to try to come up with a medication to counter that.
My question is since this is all based on defective genes and so on that create these rare diseases, is there any innovation going on in technology—for example, there's a piece of equipment called GeneXpert that's being developed in Canada—to actually predict some of these things ahead of time?
Are you including any of that innovation in technology into the framework process?